Mechanistic studies on the inhibition of stromelysin by a peptide phosphonamidate

Citations of this article
Mendeley users who have this article in their library.
Get full text


We have investigated the inhibition of the human matrix metalloproteinase stromelysin (SLN) by the peptide phosphonamidate, phthaloyl-N-(CH2)4-P(O2--Ile -(β-naphthyl)Ala-NH-CH3, and find that it is a potent, slow-binding inhibitor of SLN with kon = 2.7 × 104 M-1 sec-1, koff = 1.9 x 10-4 sec-1, and Ki = 7 nM (pH 5.0, 25°C). To probe the mechanism of inhibition, we determined pH-dependencies and solvent deuterium isotope effects. pH-dependencies of the kinetic parameters for inhibition are complex but reflect greater inhibitory potency at lower pH and suggest a mechanism for inhibition that involves the same active site groups as are involved in catalysis. The solvent isotope on kon (kon,H2O/kon,D2O) is normal and equals 1.5 ± 0.1. Together with the pH-dependence of inhibition, this value suggests that kon is rate-limited by a process that involves general-acid/general-base catalysis. We propose that kon is rate-limited by general-acid catalyzed ligand exchange of inhibitor for the zinc-bound water molecule. © 1993.




Izquierdo-Martin, M., & Ross L., S. (1993). Mechanistic studies on the inhibition of stromelysin by a peptide phosphonamidate. Bioorganic and Medicinal Chemistry, 1(1), 19–26.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free